Author： Towse A.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.13, Iss.3, 1998-03, pp. : 271-276
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The pros and cons of Rx-to-OTC switching of drugs in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
The pros and cons of Rx-to-OTC switching of drugs in the US
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
Pros and Cons for the Development of New Antiepileptic Drugs
By Bialer M.
CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. :
Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. :